Abstract

As a promising alternative to autologous nerve grafts, tissue-engineered nerve grafts have been extensively studied as a way to bridge peripheral nerve defects and guide nerve regeneration. The main difference between autogenous nerve grafts and tissue-engineered nerve grafts is the regenerative microenvironment formed by the grafts. If an appropriate regenerative microenvironment is provided, the repair of a peripheral nerve is feasible. In this study, to mimic the body’s natural regenerative microenvironment closely, we co-cultured Schwann cells (SCs) and adipose-derived stem cells (ADSCs) as seed cells and introduced them into a silk fibroin (SF)/collagen scaffold to construct a tissue-engineered nerve conduit (TENC). Twelve weeks after the three different grafts (plain SF/collagen scaffold, TENC, and autograft) were transplanted to bridge 1-cm long sciatic nerve defects in rats, a series of electrophysiological examinations and morphological analyses were performed to evaluate the effect of the tissue-engineered nerve grafts on peripheral nerve regeneration. The regenerative outcomes showed that the effect of treatment with TENCs was similar to that with autologous nerve grafts but superior to that with plain SF/collagen scaffolds. Meanwhile, no experimental animals had inflammation around the grafts. Based on this evidence, our findings suggest that the TENC we developed could improve the regenerative microenvironment and accelerate nerve regeneration compared to plain SF/collagen and may serve as a promising strategy for peripheral nerve repair.

Highlights

  • Despite great improvements in microsurgical techniques, the repair of a peripheral nerve injury (PNI) remains a challenging clinical problem

  • We introduced a co-culture system of Schwann cells (SCs) and adipose-derived stem cells (ADSCs) into an silk fibroin (SF)/collagen scaffold to construct a tissue-engineered nerve conduit (TENC)

  • The photographs of the immunocytochemical assessment revealed that the SCs were positive for the S100 protein, and the positive rate was higher than 90% (Fig 1B–1D)

Read more

Summary

Introduction

Despite great improvements in microsurgical techniques, the repair of a peripheral nerve injury (PNI) remains a challenging clinical problem. A PNI is generally treated with autologous nerve transplantation [1,2]. Various strategies have been used in an attempt to stimulate peripheral axonal growth. Cell transplantation therapy has been regarded an effective method because of the release of various growth factors that promote axonal growth [7,8]. Different types of artificial or biological grafts have been developed and investigated to protect axonal regeneration from the infiltration of fibrous scar tissue and to provide suitable mechanical guidance for regenerating nerve fibers [9,10]. Tissue-engineered nerve grafts are typically constructed by a combination of neural scaffolds and various support cells and/or growth factors

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call